These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35563197)

  • 1. Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis.
    Walker AC; Bhargava R; Dove AS; Brust AS; Owji AA; Czyż DM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate.
    Walker AC; Bhargava R; Vaziriyan-Sani AS; Pourciau C; Donahue ET; Dove AS; Gebhardt MJ; Ellward GL; Romeo T; Czyż DM
    PLoS Pathog; 2021 May; 17(5):e1009510. PubMed ID: 33956916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases.
    Nussbaum-Krammer CI; Morimoto RI
    Dis Model Mech; 2014 Jan; 7(1):31-9. PubMed ID: 24396152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular protein homeostasis in neurodegenerative diseases.
    Wilson MR; Satapathy S; Vendruscolo M
    Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Protein Aggregates: Formation, Biological Effects, and Ways of Elimination.
    Wen JH; He XH; Feng ZS; Li DY; Tang JX; Liu HF
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.
    Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI
    Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    Garcia Manriquez BA; Papapanagiotou JA; Strysick CA; Green EH; Kikis EA
    PLoS One; 2023; 18(2):e0275137. PubMed ID: 36821635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease.
    Hipp MS; Hartl FU
    J Mol Biol; 2024 Jul; 436(14):168615. PubMed ID: 38759929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
    Walker AC; Bhargava R; Bucher M; Brust AS; Czy DM
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose delays age-dependent proteotoxicity.
    Tauffenberger A; Vaccaro A; Aulas A; Vande Velde C; Parker JA
    Aging Cell; 2012 Oct; 11(5):856-66. PubMed ID: 22734670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of protein homeostasis and aggregation.
    Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
    J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
    Walker AC; Bhargava R; Bucher MJ; Argote YM; Brust AS; Czyż DM
    iScience; 2024 Sep; 27(9):110828. PubMed ID: 39310761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental factors modulating protein conformations and their role in protein aggregation diseases.
    Devi S; Chaturvedi M; Fatima S; Priya S
    Toxicology; 2022 Jan; 465():153049. PubMed ID: 34818560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic screening strategy identifies novel regulators of the proteostasis network.
    Silva MC; Fox S; Beam M; Thakkar H; Amaral MD; Morimoto RI
    PLoS Genet; 2011 Dec; 7(12):e1002438. PubMed ID: 22242008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical kinetics for drug discovery to combat protein aggregation diseases.
    Arosio P; Vendruscolo M; Dobson CM; Knowles TP
    Trends Pharmacol Sci; 2014 Mar; 35(3):127-35. PubMed ID: 24560688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oh my gut! Is the microbial origin of neurodegenerative diseases real?
    Walker A; Czyz DM
    Infect Immun; 2023 Oct; 91(10):e0043722. PubMed ID: 37750713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
    Blumenstock S; Schulz-Trieglaff EK; Voelkl K; Bolender AL; Lapios P; Lindner J; Hipp MS; Hartl FU; Klein R; Dudanova I
    EMBO J; 2021 Oct; 40(19):e107260. PubMed ID: 34410010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.